Literature DB >> 24631772

Differential effects of S100 proteins A2 and A6 on cardiac Ca(2+) cycling and contractile performance.

Wang Wang1, Michelle L Asp1, Guadalupe Guerrero-Serna1, Joseph M Metzger2.   

Abstract

Defective intracellular calcium (Ca(2+)) handling is implicated in the pathogenesis of heart failure. Novel approaches targeting both cardiac Ca(2+) release and reuptake processes, such as S100A1, have the potential to rescue the function of failing cardiac myocytes. Here, we show that two members of the S100 Ca(2+) binding protein family, S100A2 and S100A6 that share high sequence homology, differentially influence cardiac Ca(2+) handling and contractility. Cardiac gene expression of S100A2 significantly enhanced both contractile and relaxation performance of rodent and canine cardiac myocytes, mimicking the functional effects of its cardiac homologue, S100A1. To interrogate mechanism, Ca(2+) spark frequency, a measure of the gating of the ryanodine receptor Ca(2+) release channel, was found to be significantly increased by S100A2. Therapeutic testing showed that S100A2 rescued the contractile defects of failing cardiac myocytes. In contrast, cardiac expression of S100A6 had no significant effects on contractility or Ca(2+) handling. These data reveal novel differential effects of S100 proteins on cardiac myocyte performance that may be useful in application to diseased cardiac muscle.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac calcium handling; Excitation–contraction coupling; Gene therapy; Heart failure; S100 proteins

Mesh:

Substances:

Year:  2014        PMID: 24631772      PMCID: PMC4041381          DOI: 10.1016/j.yjmcc.2014.03.003

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  50 in total

Review 1.  Electrophysiological remodeling in hypertrophy and heart failure.

Authors:  G F Tomaselli; E Marbán
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

Review 2.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

Review 3.  Calcium cycling in congestive heart failure.

Authors:  Gerd Hasenfuss; Burkert Pieske
Journal:  J Mol Cell Cardiol       Date:  2002-08       Impact factor: 5.000

Review 4.  Regulation of Na+/Ca2+ exchange current in the normal and failing heart.

Authors:  Michael Reppel; Bernd K Fleischmann; Hannes Reuter; Frank Pillekamp; Heribert Schunkert; Jürgen Hescheler
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

Review 5.  Adenovirus-mediated myofilament gene transfer into adult cardiac myocytes.

Authors:  M V Westfall; E M Rust; F Albayya; J M Metzger
Journal:  Methods Cell Biol       Date:  1997       Impact factor: 1.441

6.  Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy.

Authors:  A Remppis; T Greten; B W Schäfer; P Hunziker; P Erne; H A Katus; C W Heizmann
Journal:  Biochim Biophys Acta       Date:  1996-10-11

7.  Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs.

Authors:  Dewayne Townsend; Immanuel Turner; Soichiro Yasuda; Joshua Martindale; Jennifer Davis; Michael Shillingford; Joe N Kornegay; Joseph M Metzger
Journal:  J Clin Invest       Date:  2010-03-15       Impact factor: 14.808

8.  Ca2+ cycling and new therapeutic approaches for heart failure.

Authors:  Anne-Marie Lompré; Roger J Hajjar; Sian E Harding; Evangelia G Kranias; Martin J Lohse; Andrew R Marks
Journal:  Circulation       Date:  2010-02-01       Impact factor: 29.690

9.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

Review 10.  Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies.

Authors:  Marcus C Schaub; Claus W Heizmann
Journal:  Biochem Biophys Res Commun       Date:  2007-10-25       Impact factor: 3.575

View more
  4 in total

Review 1.  Cardiac gene therapy: are we there yet?

Authors:  P N Matkar; H Leong-Poi; K K Singh
Journal:  Gene Ther       Date:  2016-04-29       Impact factor: 5.250

Review 2.  Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review.

Authors:  Egidio Imbalzano; Giuseppe Mandraffino; Marco Casciaro; Sebastiano Quartuccio; Antonino Saitta; Sebastiano Gangemi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

3.  Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia-Reperfusion.

Authors:  Azadeh Mofid; Nadav S Newman; Paul J H Lee; Cynthia Abbasi; Pratiek N Matkar; Dmitriy Rudenko; Michael A Kuliszewski; Hao H Chen; Kolsoom Afrasiabi; James N Tsoporis; Anthony O Gramolini; Kim A Connelly; Thomas G Parker; Howard Leong-Poi
Journal:  J Am Heart Assoc       Date:  2017-02-07       Impact factor: 5.501

Review 4.  Involvement of Oxidative Stress in Protective Cardiac Functions of Calprotectin.

Authors:  Luc Rochette; Geoffrey Dogon; Eve Rigal; Marianne Zeller; Yves Cottin; Catherine Vergely
Journal:  Cells       Date:  2022-04-05       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.